ISS recommends Aptose shareholders vote FOR Hanmi arrangement at C$2.41/share

Aptose Biosciences Inc.

ISS recommends voting FOR the arrangement with Hanmi Pharmaceutical and the continuance to ABCA.
Shareholders to receive C$2.41 per share cash, a 28% premium over the 30-day VWAP of C$1.88.
Special meeting reconvened to March 31, 2026; proxy deadline is March 27, 2026 at 11:00 AM ET.
Board of directors unanimously recommends approval of the arrangement resolution.
Completion subject to court approval, TSX approval, and other customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.